β Banking With Billy News
$TVRD π +37% AH
πΉοΈ Tvardi Therapeutics is a clinical-stage biotech focused on STAT3 inhibitors for cancer, fibrosis + inflammatory diseases π
πΉοΈ Big after-h
Breakout Stocks β’ 2026-06-26 20:40 UTC β’ By Billy Odell Tucker-Robinson
$TVRD π +37% AH
πΉοΈ Tvardi Therapeutics is a clinical-stage biotech focused on STAT3 inhibitors for cancer, fibrosis + inflammatory diseases π
πΉοΈ Big after-hours move bringing fresh attention back to the name π
πΉοΈ Biotech momentum can move fast when news + volume hit together β‘
πΉοΈ Traders watcβ¦
📚 More from Billy’s World
Banking With Billy News Network β bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y β’
YouTube: @BankingWithBilly